EUR 8.31
(1.03%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 15.29 Million EUR | -90.17% |
2022 | 155.49 Million EUR | -18.0% |
2021 | 189.61 Million EUR | -43.79% |
2020 | 337.34 Million EUR | -12.47% |
2019 | 385.39 Million EUR | -14.4% |
2018 | 450.21 Million EUR | 750.07% |
2017 | 52.96 Million EUR | -40.58% |
2016 | 89.12 Million EUR | 135.49% |
2015 | -251.16 Million EUR | -662.71% |
2014 | 44.63 Million EUR | -79.35% |
2013 | 216.15 Million EUR | 1399.86% |
2012 | -16.62 Million EUR | -110.17% |
2011 | 163.5 Million EUR | 1161.72% |
2010 | -15.4 Million EUR | -356.67% |
2009 | 6 Million EUR | -95.55% |
2008 | 134.9 Million EUR | -70.03% |
2007 | 450.07 Million EUR | 4461.84% |
2006 | 9.86 Million EUR | 102.03% |
2005 | -485.51 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 38 Million EUR | 309.62% |
2024 Q2 | 63.36 Million EUR | 108.55% |
2023 Q2 | 171.34 Million EUR | 5.38% |
2023 FY | 15.29 Million EUR | -90.17% |
2023 Q1 | 162.6 Million EUR | 4.57% |
2023 Q3 | 104.9 Million EUR | -38.78% |
2023 Q4 | 9.27 Million EUR | -91.16% |
2022 Q2 | 167.09 Million EUR | 0.0% |
2022 FY | 155.49 Million EUR | -18.0% |
2022 Q4 | 155.49 Million EUR | 0.0% |
2021 Q4 | 189.61 Million EUR | -11.27% |
2021 Q2 | 277.12 Million EUR | -33.16% |
2021 FY | 189.61 Million EUR | -43.79% |
2021 Q1 | 414.6 Million EUR | 22.9% |
2021 Q3 | 213.7 Million EUR | -22.89% |
2020 Q1 | 385.7 Million EUR | 0.08% |
2020 Q2 | 393.49 Million EUR | 2.02% |
2020 FY | 337.34 Million EUR | -12.47% |
2020 Q4 | 337.34 Million EUR | -8.63% |
2020 Q3 | 369.2 Million EUR | -6.17% |
2019 Q2 | 499.53 Million EUR | 2.78% |
2019 FY | 385.39 Million EUR | -14.4% |
2019 Q1 | 486 Million EUR | 7.95% |
2019 Q3 | 470.3 Million EUR | -5.85% |
2019 Q4 | 385.39 Million EUR | -18.05% |
2018 FY | 450.21 Million EUR | 750.07% |
2018 Q2 | -42.56 Million EUR | -427.44% |
2018 Q3 | 482.5 Million EUR | 1233.51% |
2018 Q1 | 13 Million EUR | -75.45% |
2018 Q4 | 450.21 Million EUR | -6.69% |
2017 Q3 | 24.6 Million EUR | 120.99% |
2017 Q4 | 52.96 Million EUR | 115.29% |
2017 Q2 | -117.17 Million EUR | -47.76% |
2017 Q1 | -79.3 Million EUR | -188.97% |
2017 FY | 52.96 Million EUR | -40.58% |
2016 Q1 | -172.4 Million EUR | 31.36% |
2016 FY | 89.12 Million EUR | 135.49% |
2016 Q3 | -183.2 Million EUR | -10.34% |
2016 Q4 | 89.12 Million EUR | 148.65% |
2016 Q2 | -166.02 Million EUR | 3.7% |
2015 Q1 | -516.1 Million EUR | -1256.29% |
2015 Q3 | -489.9 Million EUR | -8950.43% |
2015 Q4 | -251.16 Million EUR | 48.73% |
2015 FY | -251.16 Million EUR | -662.71% |
2015 Q2 | -5.41 Million EUR | 98.95% |
2014 Q4 | 44.63 Million EUR | -80.86% |
2014 FY | 44.63 Million EUR | -79.35% |
2014 Q2 | 248.25 Million EUR | 7.94% |
2014 Q1 | 230 Million EUR | 6.41% |
2014 Q3 | 233.2 Million EUR | -6.06% |
2013 Q2 | -21.88 Million EUR | 39.03% |
2013 Q3 | -48.7 Million EUR | -122.5% |
2013 Q4 | 216.15 Million EUR | 543.85% |
2013 FY | 216.15 Million EUR | 1399.86% |
2013 Q1 | -35.9 Million EUR | -115.89% |
2012 Q3 | -103.6 Million EUR | -195.79% |
2012 Q4 | -16.62 Million EUR | 83.95% |
2012 FY | -16.62 Million EUR | -110.17% |
2012 Q1 | -52 Million EUR | -131.8% |
2012 Q2 | -35.02 Million EUR | 32.64% |
2011 Q2 | -15.9 Million EUR | 58.81% |
2011 Q3 | -49.2 Million EUR | -209.43% |
2011 Q4 | 163.5 Million EUR | 432.33% |
2011 FY | 163.5 Million EUR | 1161.72% |
2011 Q1 | -38.6 Million EUR | -150.65% |
2010 Q1 | -12.1 Million EUR | -301.67% |
2010 Q4 | -15.4 Million EUR | -120.0% |
2010 FY | -15.4 Million EUR | -356.67% |
2010 Q3 | -7 Million EUR | 48.15% |
2010 Q2 | -13.5 Million EUR | -11.57% |
2009 FY | 6 Million EUR | -95.55% |
2009 Q4 | 6 Million EUR | 0.0% |
2008 FY | 134.9 Million EUR | -70.03% |
2007 FY | 450.07 Million EUR | 4461.84% |
2006 FY | 9.86 Million EUR | 102.03% |
2005 FY | -485.51 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Faes Farma, S.A. | -10.75 Million EUR | 242.238% |
Laboratorio Reig Jofre, S.A. | 55.48 Million EUR | 72.439% |